Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00632307
What this trial is testing

Breath Analysis by Ion Mobility Spectrometry

Who this might be right for
Lung Diseases
Lung Clinic Hemer 1,000
Not applicableStudy completedNCT00705198
What this trial is testing

Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)

Who this might be right for
GliomaAstrocytoma
Merck Sharp & Dohme LLC 1,804
Not applicableStudy completedNCT03303365
What this trial is testing

Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence

Who this might be right for
Brain MetastasesAdult Solid Tumor
Juergen Debus 203
Large-scale testing (Phase 3)Study completedNCT03038100
What this trial is testing

Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Hoffmann-La Roche 1,301
Post-approval studies (Phase 4)Looking for participantsNCT06072807
What this trial is testing

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Study completedNCT00003667
What this trial is testing

Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00636571
What this trial is testing

Feasibility of Exercise With Post-Op Lung Cancer Patients

Who this might be right for
Non-Small Cell Lung Cancer
Duke University 21
Testing effectiveness (Phase 2)Study completedNCT00098774
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 47
Not applicableUnknownNCT00145288
What this trial is testing

Prospective Study of Patients With Hirsutism

Who this might be right for
HirsutismType 2 DiabetesPolycystic Ovary Syndrome
Odense University Hospital 340
Not applicableStudy completedNCT00388024
What this trial is testing

PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
Wake Forest University Health Sciences 19
Not applicableActive Not RecruitingNCT06494241
What this trial is testing

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

Who this might be right for
Carcinoma, Non-Small-Cell LungLung NeoplasmsRespiratory Tract Neoplasms+7 more
AstraZeneca 1,000
Testing effectiveness (Phase 2)Study completedNCT00003151
What this trial is testing

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 96
Not applicableStudy completedNCT02121418
What this trial is testing

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

Who this might be right for
Chronic Myelomonocytic Leukemia-2Myelodysplastic SyndromeMyeloproliferative Neoplasm+1 more
University of Washington 12
Testing effectiveness (Phase 2)Study completedNCT00570180
What this trial is testing

Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 36
Testing effectiveness (Phase 2)Study completedNCT01446562
What this trial is testing

Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Sunnybrook Health Sciences Centre 34
Not applicableUnknownNCT02603627
What this trial is testing

Prevalence of COPD in Our Lung Cancer Population, Compared to Controls

Who this might be right for
COPDLung CancerSmoking
Guy's and St Thomas' NHS Foundation Trust 200
Not applicableNot Yet RecruitingNCT06776120
What this trial is testing

Fecal Immunochemical Test in Diagnosing Colorectal Cancer Among Vietnamese Patients with Lower Gastrointestinal Symptoms

Who this might be right for
Colorectal Cancer (CRC)
Luu Ngoc Mai 1,575
Testing effectiveness (Phase 2)UnknownNCT00438841
What this trial is testing

Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 43
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Early research (Phase 1)Study completedNCT00990054
What this trial is testing

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Genzyme, a Sanofi Company 36
Next Page